Related Experiment Video
Updated: May 27, 2025

05:49
Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
Published on: November 1, 2024
682
Behavioral interventions for migraine prevention: A systematic review and meta-analysis
Jonathan R Treadwell1, Amy Y Tsou1, Benjamin Rouse1
1ECRI, Plymouth Meeting, Pennsylvania, USA.
Headache
|February 19, 2025
Summary
Behavioral interventions like cognitive behavioral therapy (CBT), relaxation training, and mindfulness may reduce migraine frequency in adults. For children, a combination of CBT, biofeedback, and relaxation training shows promise in reducing migraine frequency and disability.
Area of Science:
- Neurology and Behavioral Medicine
- Evidence Synthesis and Systematic Review
- Clinical Trial Analysis
Background:
- Migraine prevention in children and adults lacks recent systematic reviews on behavioral interventions.
- Understanding the efficacy and safety of these non-pharmacological approaches is crucial for patient care.
Purpose of the Study:
- To synthesize existing evidence on the benefits and harms of behavioral interventions for migraine prevention.
- To evaluate the efficacy and safety of various behavioral therapies in reducing migraine frequency, disability, and improving quality of life.
Main Methods:
- Systematic literature search of randomized trials from 1975 to 2023 across multiple databases.
- Inclusion of trials on behavioral interventions for migraine prevention in children and adults.
- Data synthesis using meta-analysis where appropriate, with strength of evidence (SOE) rating.
Main Results:
- For adults, cognitive behavioral therapy (CBT), relaxation training, and mindfulness-based therapies showed low SOE for reducing migraine frequency.
- Education alone demonstrated low SOE for improving migraine-related disability in adults.
- For children/adolescents, CBT + biofeedback + relaxation training showed low SOE for reducing migraine frequency and disability compared to education alone.
Conclusions:
- Behavioral interventions, including CBT, relaxation, and mindfulness, show potential for migraine prevention in adults, while specific combinations show promise in children.
- The evidence base is limited by underpowered trials, high risk of bias, and inconsistencies in intervention components and reporting.
- Future research needs larger, well-designed trials with standardized components, appropriate control groups, and investigation of digital delivery methods.
Related Concept Videos
Cholinergic Antagonists: Therapeutic Uses
703
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
703
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
525
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
525

